The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...
More »SEARCH RESULT
Total Matching Records found : 196
Gadchiroli’s trudging doctors spell hope-Pramit Bhattacharya
A healthcare model relying mainly on people from within the community to provide care is reaping success One of India’s most backward districts and Maharashtra’s worst ranked in human development indicators, Gadchiroli, today finds itself at the forefront of a healthcare revolution that can potentially save millions of infant lives and help India rapidly reduce her abysmal infant mortality rate (IMR). Under the aegis of the National Rural Health Mission (NRHM), India...
More »No Guarantee of Food Security in Children’s Incredible India by Razia Ismail
India’s decision-makers seem to find it difficult to see that there are children in the country. Being unable to see them, they are unable to perceive that they are hungry. In an age when we are able to use euphemisms like ‘under-nutrition’, this is perhaps not surprising. But it is disgraceful none the less. This country has a large population of children. Fortyone per cent of its total numbers. The national...
More »Centre to hold talks with states on GM crops trials by Ravish Tiwari
Genetic Engineering Appraisal Committee (GEAC), the apex authority for approval of large-scale Field Trials and commercialisation of GM crops, has decided to hold “dialogue” with state governments to iron out irritants being faced in the grant of no objection certificates (NOC) for GM crops’ trials. The development comes after the Centre’s Review Committee on Genetic Manipulation and GM seed industry association petitioned the GEAC regarding the delay or denial of NOC...
More »No nod, yet Monsanto tried GM maize: RTI by Zia Haq
US biotech firm Monsanto had put a variety of genetically modified maize on trial without permission and India's biotech regulatory panel overlooked the violation, according to facts accessed under RTI, a leading anti-GM body has said. Such violations could queer the pitch for the biotech giant and sharpen criticism that it pays scant regards to rules, even though Indian farmers have widely taken to its variety of BT cotton, which has...
More »
